Press
Release

NATROX® Wound Care Ranks Number One for its Innovative Medical Technology

NATROX® Wound Care, an Inotec AMD brand, is pleased to announce it has ranked number one in the MedTech50, recognised as the UK’s most innovative medical technology creator for 2022. The Business Cloud award honours companies helping diagnose and treat conditions mainly in a clinical setting. It spotlights the top 50 UK firms blazing a trail by creating original technology for the healthcare and medical sectors.

For the third consecutive year, the company has ranked in the top 50. However, this year, it catapulted its way to first place. The final MedTech50 ranking was decided by a combination of an independent judging panel and a public vote on the shortlist of companies which attracted around 800 votes. See the final Top 50 list here.

“We’re honoured to be recognised as the top forward-thinking company in the UK who are finding unique ways to support clinicians and empower patients,” said Craig Kennedy, CEO of NATROX® Wound Care. “Our team has seen how our products transform lives. Now the rest of the world is beginning to see this too. It’s an exciting time, as we feel we’re on the precipice of greatness.”

The company received accolades for its NATROX® Oxygen Wound Therapy product, which helps patients with chronic wounds using the natural healing properties of oxygen. Chronic wounds pose a significant problem both on patient quality of life and costs to healthcare systems worldwide¹. NATROX® O₂ is an innovative, easy-to-use device clinically proven to stimulate healing².

In keeping with its edge for innovation, the company recently launched NATROX® IQ. The advanced digital platform is designed to help clinicians manage wound care caseloads. The centralised, cloud-based hub enables clinical teams across various locations and disciplines to capture and access up-to-date patient information.

“We now have customers using both NATROX® O₂ and IQ, and the feedback has been fantastic,” explains Kennedy. “What has truly stood out to our customers is the simplicity of both these products, making adoption easy. Best of all, both products make it easier and simpler to manage chronic wounds from the comfort and convenience of the patient’s home.”

To learn more about NATROX® Wound Care and its innovative products, visit: natroxwoundcare.com

References

1. Gottrup, F. 2020. Portable, practical and effective: clinical benefits of NATROX® topical oxygen therapy. Journal of Wound Care May 2020, 29(5):53.
2. Serena TE, Bullock NM, Cole W et al. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled trial. J Wound Care 2021; 30: Suppl.5 S7-14.